{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT02439541",
      "OrgStudyIdInfo": {
        "OrgStudyId": "307-IVY-SC-001"
      },
      "Organization": {
        "OrgFullName": "Affiliated Hospital to Academy of Military Medical Sciences",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Ischemic Cardiomyopathy",
      "OfficialTitle": "Safety and Efficacy of Human Umbilical-Cord-derived Mesenchymal Stem Cell Transplantation in Ischemic Cardiomyopathy",
      "Acronym": "UCMSC-Heart"
    },
    "StatusModule": {
      "StatusVerifiedDate": "March 2016",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "May 2015"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "December 2017",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "December 2018",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "May 5, 2015",
      "StudyFirstSubmitQCDate": "May 7, 2015",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "May 8, 2015",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "March 14, 2016",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "March 16, 2016",
        "LastUpdatePostDateType": "Estimate"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Affiliated Hospital to Academy of Military Medical Sciences",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Ivy Institute of Stem Cells Co. Ltd",
            "CollaboratorClass": "INDUSTRY"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "Phase I-II Clinical Trial-Safety and efficacy of umbilical cord derived mesenchymal stem cells (UC-MSCs) in patients with chronic heart ischemia cohort and perspective study.",
      "DetailedDescription": "Phase I-II Clinical Trial-Safety and efficacy of umbilical-cord-derived mesenchymal stem cell (UC-MSC) in patients with chronic heart ischemia cohort and prospective study.\n\nForty patients will be selected and divided into two groups according to patients' willingness to stem cell treatment. The patients who are willing to receive stem cell transplantation will receive UC-MSCs by coronary injection. The patients in control group will not receive any intervention.\n\nEvery patient will maintain their standard treatment of chronic heart ischemia, with maximum tolerated dosage without side effects.\n\nThe day of infusion will be considered day zero. From that moment, followup will be divided into 0-1,1-3, 3-6, and 6-12 months.\n\nClinical results will be analyzed after completion of 12 months of followup."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Chronic Ischemic Heart Disease",
          "Heart Failure",
          "Angina"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "cellular therapy",
          "Chronic ischemic heart disease",
          "phase 1/2 clinical study",
          "human umbilical cord mesenchymal stem cell",
          "ischemic heart disease",
          "allogeneic stem cell transplantation"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Non-Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "40",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "UCMSC group",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Patients in this arm received umbilical cord MSCs by intracoronary injection",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: UCMSC group"
              ]
            }
          },
          {
            "ArmGroupLabel": "Control group",
            "ArmGroupType": "No Intervention",
            "ArmGroupDescription": "Patients in this arm did not receive any intervention."
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "UCMSC group",
            "InterventionDescription": "Human umbilical cord MSCs are transplanted by intracoronary infusion(1×10^7)",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "UCMSC group"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Number and nature of adverse events",
            "PrimaryOutcomeDescription": "Evidence for new clinical/biological abnormalities.",
            "PrimaryOutcomeTimeFrame": "Within the first year after intracoronary infusion"
          },
          {
            "PrimaryOutcomeMeasure": "Incidence of major adverse coronary events (MACE)",
            "PrimaryOutcomeDescription": "Major adverse coronary events (MACE) were defined as cardiac death, non-fatal myocardial infarction, or rehospitalization for acute coronary syndrome and for congestive heart failure.",
            "PrimaryOutcomeTimeFrame": "Within the first year after intracoronary infusion"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Exercise Time and Level",
            "SecondaryOutcomeDescription": "Exercise time and level as assessed via six minute walk test.",
            "SecondaryOutcomeTimeFrame": "Post cell transplantation: 1, 3, 6, 12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Quantify myocardium perfusion measured by SPECT",
            "SecondaryOutcomeDescription": "The efficacy of UC-MSC treatment was quantified by the differences between the two groups and from baseline to 6 and 12 months in perfusion images, as measured by SPECT.",
            "SecondaryOutcomeTimeFrame": "Post cell transplantation: 6, 12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Assessment of heart function by left ventricular ejection fraction",
            "SecondaryOutcomeDescription": "Change in left ventricular ejection fraction was assessed with echocardiography after cell implantation.",
            "SecondaryOutcomeTimeFrame": "Post cell transplantation: 1, 3, 6，12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Clinical Improvement in NYHA Classification",
            "SecondaryOutcomeDescription": "The NYHA scale ranges from 1 (best)\"Mild- no limitation of physical activity due to heart failure\" to 4 (worst) \"Severe-Unable to carry out any physical activity without discomfort due to heart failure\".",
            "SecondaryOutcomeTimeFrame": "1 year"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nAge between 18 and 80 y\nNo option for PCI or CABG (Angiographies evaluated by an independent interventional cardiologist).\nMaximal tolerable angina and heart failure medication\nNYHA functional classification (I-III)\nSigned informed consent\n\nExclusion Criteria:\n\nSevere liver or renal dysfunction or hemorrhagic diseases not suitable for PCI.\nSevere cerebral ischemic stroke or cerebral hemorrhage within 6 month.\nHistory with malignant disease within 5 y of inclusion or suspected malignity\nSevere heart failure (NYHA functional classification IV)\nDiminished functional capacity for other reasons such as COPD, alcoholic cardiomyopathy, or viral myocarditis\nClinical significant anemia, leukopenia, leukocytosis,or thrombocythemia\nClinical significant abnormal prothrombin or partial thromboplastin time or anticoagulation treatment that cannot be paused during treatment\nPatients with reduced immune response or treated with immunosuppressive medication\nCombined with severe infectious diseases\nPregnant or fertile women\nSocially and mentally disabilities",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "80 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Xiaozhong Zhang, M.D",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "+86-010-66947136",
            "CentralContactEMail": "zxz947136@126.com"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Bing Liu, M.D",
            "OverallOfficialAffiliation": "307-IVY Translational Medicine Center",
            "OverallOfficialRole": "Study Chair"
          },
          {
            "OverallOfficialName": "Xiaozhong Zhang, M.D",
            "OverallOfficialAffiliation": "Department of cardiology,Affiliated Hospital to Academy of Military Medical Sciences",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Department of cardiology,Affiliated Hospital to Academy of Military Medical Sciences",
            "LocationStatus": "Recruiting",
            "LocationCity": "Beijing",
            "LocationZip": "100071",
            "LocationCountry": "China",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Xiaozhong Zhang, M.D",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "+86-010-66947136",
                  "LocationContactEMail": "zxz947136@126.com"
                }
              ]
            }
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000006331",
            "ConditionMeshTerm": "Heart Diseases"
          },
          {
            "ConditionMeshId": "D000009202",
            "ConditionMeshTerm": "Cardiomyopathies"
          },
          {
            "ConditionMeshId": "D000017202",
            "ConditionMeshTerm": "Myocardial Ischemia"
          },
          {
            "ConditionMeshId": "D000003324",
            "ConditionMeshTerm": "Coronary Artery Disease"
          },
          {
            "ConditionMeshId": "D000007511",
            "ConditionMeshTerm": "Ischemia"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000002318",
            "ConditionAncestorTerm": "Cardiovascular Diseases"
          },
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          },
          {
            "ConditionAncestorId": "D000014652",
            "ConditionAncestorTerm": "Vascular Diseases"
          },
          {
            "ConditionAncestorId": "D000003327",
            "ConditionAncestorTerm": "Coronary Disease"
          },
          {
            "ConditionAncestorId": "D000001161",
            "ConditionAncestorTerm": "Arteriosclerosis"
          },
          {
            "ConditionAncestorId": "D000001157",
            "ConditionAncestorTerm": "Arterial Occlusive Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M8571",
            "ConditionBrowseLeafName": "Heart Diseases",
            "ConditionBrowseLeafAsFound": "Heart Disease",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M9695",
            "ConditionBrowseLeafName": "Ischemia",
            "ConditionBrowseLeafAsFound": "Ischemic",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M5698",
            "ConditionBrowseLeafName": "Coronary Artery Disease",
            "ConditionBrowseLeafAsFound": "Ischemic Heart Disease",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M18658",
            "ConditionBrowseLeafName": "Myocardial Ischemia",
            "ConditionBrowseLeafAsFound": "Ischemic Heart Disease",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M8573",
            "ConditionBrowseLeafName": "Heart Failure",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11306",
            "ConditionBrowseLeafName": "Cardiomyopathies",
            "ConditionBrowseLeafAsFound": "Cardiomyopathy",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M3269",
            "ConditionBrowseLeafName": "Angina Pectoris",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5701",
            "ConditionBrowseLeafName": "Coronary Disease",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M16552",
            "ConditionBrowseLeafName": "Vascular Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M3621",
            "ConditionBrowseLeafName": "Arteriosclerosis",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M3617",
            "ConditionBrowseLeafName": "Arterial Occlusive Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC14",
            "ConditionBrowseBranchName": "Heart and Blood Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          }
        ]
      }
    }
  }
}